How Much Is Weight Loss Surgery? Cash-Pay, Insurance, Medicare & Mexico Cost Guide

Bariatric surgery price varies more than any other obesity intervention. The same sleeve gastrectomy can cost $5,500 in Tijuana, $15,000 cash at a Texas surgery center, $22,000 billed to a Massachusetts commercial insurer, or $0 out-of-pocket for a patient with a met-deductible BCBS plan and prior authorization. This article walks through every legitimate pricing pathway in 2026 — cash-pay by procedure, commercial insurance, Medicare NCD 100.1, state Medicaid variability, Mexico medical tourism, and the new GLP-1-first sequence that's reshaping the surgical pipeline. Every dollar figure is sourced from primary insurer policies, CMS coverage determinations, or published cost-effectiveness analyses.

At a glance

• Sleeve gastrectomy (most common in 2026): $15,000-$25,000 cash-pay; commercial insurance billings ~$17,000-$22,000.
• Roux-en-Y gastric bypass: $20,000-$30,000 cash-pay; commercial billings ~$18,000-$24,000.
• Intragastric balloon (Orbera, Spatz3): $6,500-$10,000 cash. Rarely covered by insurance.
• Out-of-pocket with insurance approval: typically $0-$5,000 — driven by deductible, coinsurance, and out-of-pocket max, not the billed amount.
• Mexico (Tijuana, Monterrey): sleeve $5,500-$8,500 all-inclusive; quality varies and US follow-up is on you.
• GLP-1 first: 1 year of brand Wegovy or Zepbound at retail runs $12,000-$16,000 — within shouting distance of a cash-pay sleeve.

Cash-pay cost by procedure

US cash-pay (also called "self-pay" or "direct-pay") bundles typically include the surgeon's fee, anesthesia, OR time, facility fee, one overnight hospital stay (sleeve and bypass), and a defined post-op follow-up window (usually 90 days). They generally do NOT include pre-op labs, psychological evaluation, nutrition counseling, post-op vitamin protocols, or revision surgery if needed.

• Sleeve gastrectomy (laparoscopic): the most common bariatric procedure in 2026. Cash-pay packages at high-volume US centers run $15,000-$25,000, with a typical midpoint around $18,000. Texas, Florida, and Oklahoma are consistently the lowest-cost states; California, Massachusetts, and New York routinely the highest.
• Roux-en-Y gastric bypass: $20,000-$30,000 cash. Longer OR time, more complex anatomy, and higher reoperation risk all factor into the premium versus sleeve.
• Adjustable gastric band (Lap-Band): $10,000-$17,000 cash. Largely fallen out of favor in the US — high reoperation and band-removal rates at 5+ years per the Chang 2014 JAMA Surgery meta-analysis^[5]. Many high-volume centers no longer offer it.
• Biliopancreatic diversion with duodenal switch (BPD/DS) and SADI-S: $25,000-$35,000+ cash. The most complex bariatric procedure with the largest weight loss magnitude — and the highest perioperative mortality in the Buchwald 2004 meta-analysis^[4] (1.1% vs ~0.1% for banding). Reserved for BMI 50+ patients at expert centers.
• Intragastric balloon (Orbera, Spatz3, Allurion Elipse): $6,500-$10,000 cash for a 6-month placement. Endoscopic, no surgical anatomy change. Average ~10-15% total body weight loss at 6 months in published series; weight regain is common after balloon removal unless paired with ongoing behavioral or pharmacologic therapy.
• Revisional surgery (band-to-sleeve, sleeve-to-bypass, conversion for weight regain): $25,000-$40,000+ cash, reflecting the technical complexity of operating on already altered anatomy.

Cost-by-pathway: surgery, GLP-1, and tourism

Two patterns jump out. First, insurance-covered surgery is almost always the cheapest legitimate path when the patient qualifies — the gap between a $3,500 out-of-pocket and a $14,000 year of brand-name GLP-1 widens further at year 2, year 3, year 5. Second, compounded GLP-1 therapy is the only obesity intervention that's genuinely cheap month-to-month — but it requires indefinite continuation, and discontinuation produces substantial weight regain in STEP-4 and SURMOUNT-4. The honest cost comparison is total cost over 5-10 years, not just year one.

Insurance coverage: BMI gates, the 6-month rule, psych and nutrition

Commercial insurance is the dominant coverage pathway for bariatric surgery in the US, and it's gated harder than almost any other elective procedure. The general framework — which Aetna, Cigna, UnitedHealthcare, BCBS plans, and Humana broadly converge on — looks like this:

• BMI threshold: most commercial payers still use BMI ≥40 OR BMI ≥35 with at least one obesity-related comorbidity (T2D, hypertension, OSA, severe joint disease). The ASMBS / IFSO 2022 indications statement^[1] lowered the academic threshold to BMI ≥35 regardless of comorbidities and BMI 30-34.9 with metabolic disease, but US payer policies have not uniformly adopted the lower threshold yet.
• The 6-month rule: most commercial plans require documentation of a medically supervised weight management program of 3-6 consecutive months within the 2 years preceding surgery. Monthly weights, dietitian visits, and documented behavioral counseling are typical requirements. Missing a single month often resets the clock — a major friction point.
• Psychological evaluation: a bariatric-specific psych eval is required by virtually every payer. Untreated severe depression, active substance use disorder, active eating disorder, or significant cognitive impairment can disqualify or delay approval.
• Nutrition evaluation: a registered dietitian assessment plus a structured pre-op diet (often a 2-week liver-shrinking very-low-calorie diet) is required.
• Smoking cessation: most centers require nicotine abstinence (verified by cotinine test) for at least 6-8 weeks pre-op due to anastomotic-leak risk.
• Center accreditation: insurers generally require surgery at an MBSAQIP-accredited (Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program) facility.

Medicare NCD 100.1

Medicare coverage of bariatric surgery is governed by National Coverage Determination 100.1^[9]. The current NCD covers open and laparoscopic Roux-en-Y gastric bypass, open and laparoscopic biliopancreatic diversion with duodenal switch, laparoscopic adjustable gastric banding, and laparoscopic sleeve gastrectomy when performed at a certified facility, for beneficiaries who meet all of the following:

• BMI ≥35 kg/m²
• At least one comorbidity related to obesity (T2D, hypertension, OSA, severe arthropathy, cardiomyopathy, etc.)
• Previously been unsuccessful with medical treatment for obesity

Medicare Part A covers the hospital stay; Part B covers the surgeon and anesthesiologist professional fees. After the Part A deductible (~$1,632 in 2026) and Part B coinsurance, most Medicare-covered bariatric procedures land beneficiaries in the $1,500-$3,500 out-of-pocket range, less if the patient has a Medigap supplement plan.

Medicaid varies by state

State Medicaid bariatric coverage is the most variable layer in the US payer landscape. Approximately 48 of 50 state Medicaid programs offer some level of bariatric surgery coverage in 2026, but eligibility criteria, the supervised-weight-loss program length, psych and nutrition gates, and the list of covered procedures all differ. A patient in Texas may need 6 months of supervised weight management; in another state the same patient may need 12. A handful of state Medicaid programs cover only sleeve and bypass; others cover banding and BPD/DS as well. Two states historically have not covered bariatric surgery at all. Our broader insurance coverage research breaks down the patterns.

Mexico medical tourism: $5K-$8K sleeve, but with real trade-offs

Mexico has become the dominant international destination for US bariatric tourism, with Tijuana, Monterrey, and Cancún serving the bulk of patient volume. All-inclusive sleeve gastrectomy packages typically run $5,500-$8,500, covering surgery, anesthesia, hospital stay, hotel, ground transportation, and a defined post-op follow-up window. Roux-en-Y gastric bypass runs roughly $7,500-$11,000 in the same channel.

• Accreditation to look for: Surgical Review Corporation (SRC) Center of Excellence designation, Joint Commission International (JCI) accreditation, and a surgeon credentialed by the Colegio Mexicano de Cirugía para la Obesidad y Enfermedades Metabólicas (CMCOEM).
• What's genuinely cheaper: the bundled package itself — facility, surgeon, and anesthesia cost structures in Mexico are 50-70% lower than equivalent US private centers.
• What you trade away: US-side follow-up. If a leak, stricture, or anastomotic complication develops 2 weeks after returning home, you'll be navigating an unfamiliar US surgical practice without prior chart records — and bariatric revision is the most expensive scenario on this page.
• Hidden costs: potential US emergency-room follow-up if complications arise, revision surgery in the US if the original Mexico procedure has a poor outcome, and the cost of finding a US bariatric medicine provider willing to manage a non-MBSAQIP-pedigree patient long-term.

Long-term cost-effectiveness: why surgery still wins on dollars-per-life-year

Bariatric surgery has the longest cost-effectiveness literature of any obesity intervention. The Swedish Obese Subjects (SOS) study^[3] followed 2,010 surgical patients against matched non-surgical controls for a median 10.9 years and reported a hazard ratio of 0.71 for all-cause mortality. Cause- specific reductions across SOS, Adams 2007, and the SPLENDID cohort include sharply lower cardiovascular, diabetes, and cancer mortality. The Chang 2014 JAMA Surgery meta-analysis^[5] of 161,756 patients across 164 studies (2003-2012) reported sustained 5-year excess weight loss of 56-72% (varying by procedure) and T2D remission in 66.7% of patients post-bypass.

Cost-effectiveness analyses consistently show bariatric surgery is cost-effective at standard willingness-to-pay thresholds for patients with metabolic comorbidities — and dominantly cost-saving for patients with severe diabetes or NASH cirrhosis. Klebanoff and colleagues^[6] reported in JAMA Network Open 2019 that sleeve gastrectomy and RYGB are both cost-effective (and often cost-saving) versus medical management in NASH cirrhosis, with meaningfully extended quality-adjusted life expectancy. The bigger question isn't whether surgery is cost-effective in isolation — it almost always is — but how it compares against indefinite GLP-1 therapy, where the cumulative drug cost over 10-15 years can exceed a one-time surgical spend.

GLP-1 first, surgery second: the emerging 2026 sequence

A pattern that has emerged across major obesity-medicine centers in 2025-2026 is GLP-1 first, surgery second — and increasingly the reverse, with GLP-1s used after surgery for weight regain. Both directions reshape the cost question:

• GLP-1 as a bridge to surgery: patients with severe obesity sometimes start semaglutide (STEP-1: 14.9% body weight loss^[7]) or tirzepatide (SURMOUNT-1: 20.9% body weight loss^[8]) for 6-12 months pre-op to reduce surgical risk and shrink the liver. Cost adds $3,000-$15,000 to the total pathway depending on whether brand or compounded GLP-1 is used — but reduces perioperative complication risk.
• GLP-1 as an alternative to surgery: patients with BMI 30-35 with metabolic disease are now commonly treated with GLP-1 therapy indefinitely instead of pursuing surgery, especially where insurance doesn't cover surgery at the lower BMI. The cumulative cost over 10+ years can equal or exceed a single bariatric procedure.
• GLP-1 after surgery for regain: roughly 25-30% of bariatric patients experience meaningful weight regain. GLP-1s (semaglutide, tirzepatide) are now the dominant non-revisional option, with multiple cohort studies showing meaningful additional weight loss post-bariatric. Revision surgery costs $25,000-$40,000 cash; a year of compounded GLP-1 costs ~$2,400.
• Pre-op GLP-1 considerations: the ASA 2023 guidance on perioperative GLP-1 cessation was revised in 2024 to a more permissive position. See our bariatric surgery vs GLP-1 evidence review and the decision guide for trial-by-trial detail.

Hidden and follow-on costs nobody quotes you

• Pre-op workup: labs, EKG, sleep study (often required), upper endoscopy, GI consult, cardiology clearance for patients with cardiac history. Out-of-pocket cost outside an all-inclusive package: $1,500-$4,000.
• Post-op vitamins for life: bariatric-specific multivitamin, B12, iron, calcium citrate, vitamin D — running $30-$60/month indefinitely.
• Follow-up labs: CBC, CMP, iron studies, B12, 25-OH-vitamin D, parathyroid hormone, every 6 months for the first 2 years and annually thereafter. ~$200-$500/year in cash equivalent.
• Plastic surgery for excess skin: often the biggest surprise cost. Panniculectomy, brachioplasty, thigh lift, and breast surgery after major weight loss commonly run a combined $15,000-$30,000+ cash. Rarely covered by insurance unless skin excess causes documented recurrent infections.
• Lost wages during recovery: 2-4 weeks off work for sleeve and bypass; 4-6 weeks for BPD/DS. Unpaid leave costs add up fast for hourly workers.

Verdict and bottom line

• Cash-pay US weight loss surgery costs $15,000-$30,000+ depending on procedure, geographic location, and surgeon volume. Sleeve gastrectomy is the cheapest mainstream option; intragastric balloon is cheaper still but produces less durable weight loss.
• Insurance-covered surgery is almost always the cheapest path when the patient qualifies — typical out-of-pocket lands in the $0-$5,000 range, gated by BMI ≥35 (+ comorbidity), a 6-month supervised program, psych and nutrition evaluation, and MBSAQIP-center surgery.
• Medicare NCD 100.1^[9] covers RYGB, BPD/DS, banding, and sleeve at certified facilities for beneficiaries with BMI ≥35 + comorbidity who've failed medical management. Out-of-pocket is generally $1,500-$3,500.
• State Medicaid varies — most cover bariatric surgery, but eligibility, supervised-program length, and covered procedures differ state by state.
• Mexico tourism cuts the cash price 50-70% but shifts complication and follow-up risk back to the patient and US-side care infrastructure.
• GLP-1s are reshaping the sequence — used as a bridge to surgery, an alternative to surgery for lower BMI, and the dominant non-revisional option for post-bariatric weight regain. The honest cost comparison is 5-10 years out, not month one.

Related research

• Bariatric surgery vs GLP-1: a head-to-head evidence review
• Bariatric surgery vs GLP-1 vs combination — decision guide with 13 verified trials
• GLP-1 insurance coverage: Medicare, Medicaid, and commercial
• Where to buy semaglutide in 2026
• Where to buy tirzepatide in 2026
• GLP-1 side effect questions answered

Important disclaimer. This article is educational and does not constitute medical or financial advice. Bariatric surgery pricing varies substantially by region, surgeon, facility, insurance plan, and individual clinical history. Every quoted figure is approximate and should be verified directly with the surgical center, insurance carrier, or Medicare/Medicaid benefits office before financial planning. Primary sources (PubMed, ASMBS/IFSO, CMS NCD 100.1) were independently verified by a research subagent on the publication date. Weight Loss Rankings has no financial relationship with any bariatric center or manufacturer referenced.